Meeting
2013 ASCO Annual Meeting
Day 100 peripheral blood absolute monocyte/lymphocyte count prognostic score and survival in diffuse large B-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation.
Authors
Ana I. Velazquez
Mayo Clinic, Rochester, MN
Ana I. Velazquez , Svetomir Markovic , David James Inwards , Ivana N. M. Micallef , Patrick B. Johnston , William J. Hogan , Stephen Maxted Ansell , Luis F. Porrata
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Autologous Bone Marrow
Citation
J Clin Oncol 31, 2013 (suppl; abstr 7041)
DOI
10.1200/jco.2013.31.15_suppl.7041
Abstract #
7041
Poster Bd #
35A
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Diffuse large B-cell lymphoma: A single-institution experience of patient outcomes.
First Author: Ryan James Chan
Poster
2012 ASCO Annual Meeting
Comparison of the international prognostic factors index (IPI) with the absolute monocyte and lymphocyte prognostic index (AMLPI) for patients (Pts) with diffuse large b-cell lymphoma (DLBCL) receiving R-CHOP.
First Author: Nicolas Batty
Poster
2022 ASCO Annual Meeting
Prognostic factors for patients with advanced renal cell carcinoma (aRCC) in the era of first-line (1L) treatment with immune checkpoint inhibitors (ICIs).
First Author: Charlene Mantia
Poster
2021 ASCO Annual Meeting
Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL).
First Author: Kana Miyazaki